section name header
Index
Alcoholic Liver Disease (Ald)
Antihypertensive Treatment for Kidney Transplant Recipients
Antiviral Therapy for Recurrent Liver Graft Infection with Hepatitis C Virus
Autoimmune Hepatitis
Calcineurin Inhibitor Withdrawal or Tapering for Kidney Transplant Recipients
Cancer of the Liver and the Biliary Tract
Cirrhosis of the Liver
Cirrhosis of the Liver - Related Resources
Clostridioides Difficile Diarrhoea
Colonoscopy and Sigmoidoscopy
Cyclosporin A for Primary Biliary Cirrhosis
Cytomegalovirus Prophylaxis with Antiviral Agents for Solid Organ Transplantation
D-Penicillamine for Primary Biliary Cirrhosis
Evidence summary
Exercise-Based Cardiac Rehabilitation in Heart Transplant Recipients
Fish Oil for Kidney Transplant Recipients
Functional Bowel Disorders and the Irritable Bowel Syndrome (Ibs)
Glucocorticosteroid Avoidance for Liver Transplanted Patients
Immunoglobulins, Vaccines or Interferon for Preventing Cytomegalovirus Disease in Solid Organ Transplant Recipients
Infectious diseases
Interleukin 2 Receptor Antagonists for Kidney Transplant Recipients
Internal medicine
Maintenance Immunosuppression for Liver Transplanted Patients
Methotrexate for Primary Biliary Cirrhosis
Mycophenolic Acid for Kidney Transplant Recipients
Nephrology
Organ Transplant Recipient in Primary Health Care
Organ Transplant Recipient in Primary Health Care - Related Resources
Pre-Emptive Antiviral Treatment to Prevent Cytomegalovirus Disease in Solid Organ Transplant Recipients
Prevention of Bone Disease in Kidney Transplant Recipients
Primary Biliary Cholangitis
Primary Biliary Cirrhosis - Related Resources
Primary Sclerosing Cholangitis
Red Cell Transfusion for the Management of Upper Gastrointestinal Haemorrhage
Sirolimus and Everolimus for Primary Immunosuppression in Kidney Transplant Recipients
Statins for Kidney Transplant Recipients
Steroid Avoidance or Withdrawal for Kidney Transplant Recipients
Surgery
Transplantation and Quality of Life
Treatment of Hepatocellular Carcinoma Associated with Cirrhosis
Ursodeoxycholic Acid in the Treatment of Primary Biliary Cirrhosis
Viral Hepatitis